The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Survivors of Hodgkin lymphoma (HL) in childhood have an increased risk of subsequent malignant neoplasms (SMNs). Herein, the authors extended the follow‐up of a previously reported Late Effects Study Group cohort and identified patients at highest risk for SMNs to create evidence for risk‐based screening recommendations.
Methods
The standardized incidence ratio was calculated using rates...
BackgroundVascular‐related toxicities have been reported among survivors of Hodgkin lymphoma (HL), but their genesis is not well understood.
ProcedureFasting blood samples from 25 previously irradiated HL survivors were analyzed for biomarkers that can reveal underlying inflammation and/or endothelial cell activation: high‐sensitivity C‐reactive protein (hsCRP), triglycerides, total cholesterol,...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.